Industry

FDA clears Oculus Pentacam Cornea OCT

Healio Optometry1d ago1 min read

Editor’s note: This is a developing news story. Please check back soon for updates.Oculus received FDA clearance for its Pentacam Cornea OCT system, according to a company press release.Pentacam Cornea OCT features a combination of Scheimpflug technology and high-resolution, pericentric optical coherence tomography imaging. Both measurements can be taken at the same time at the same location, according to the release.The system is compatible with existing Oculus Pentacam examination data, which the company said will simplify follow-up exams and progression analysis.“We are excited to

Read full article on Healio Optometry

AI Summary

Quick Take

Oculus has received FDA clearance for the Pentacam Cornea OCT, a new diagnostic system that integrates traditional Scheimpflug technology with high-resolution, pericentric optical coherence tomography. This hybrid platform allows clinicians to capture both measurement types simultaneously at the same location, streamlining anterior segment imaging.

Why It Matters

The integration of Scheimpflug tomography and OCT imaging into a single device represents a significant step forward in corneal diagnostics and refractive surgery screening. While Scheimpflug imaging is a standard for corneal shape, adding high-resolution OCT provides deeper structural insights into the corneal layers. By maintaining compatibility with existing Pentacam data, Oculus ensures that practitioners can transition to this new technology without losing the ability to perform long-term progression analysis on their current patient base.

Key Details

Combines Scheimpflug technology with high-resolution, pericentric optical coherence tomography (OCT).
Enables simultaneous acquisition of both measurement types at the exact same corneal location.
Fully compatible with existing Oculus Pentacam examination data for seamless follow-up and progression analysis.
Received formal FDA clearance for clinical use in the United States.
Designed to simplify the diagnostic process for corneal assessment and disease monitoring.

Practice Implications

Clinicians can expect a more efficient workflow by obtaining comprehensive tomographic and structural data in a single exam, reducing the need for multiple devices. The system's ability to sync with historical Pentacam data makes it a practical upgrade for monitoring keratoconus progression and evaluating refractive surgery candidates.

Who's Affected

Refractive SurgeonsCorneal SpecialistsComprehensive OptometristsOphthalmic Technicians

What's Next

Following the FDA clearance, Oculus is expected to release further details regarding the commercial availability and rollout of the Pentacam Cornea OCT. Practitioners should watch for updates on how this system integrates into existing clinical networks and any specific software requirements for data migration.

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.